Literature DB >> 14504765

[State and development of uterine myoma embolization in Germany].

T F Jakobs1, T K Helmberger, M F Reiser.   

Abstract

BACKGROUND: To evaluate the current situation and implementation of embolization of uterine leiomyomas into the treatment concept in women with symptomatic uterine leiomyomas in Germany.
MATERIAL AND METHODS: A questionnaire addressing the clinical background of uterine myomas, recommended treatment concepts, preclinical evaluation, technical approach and complications was sent to 164 departments of gynecology and radiology in Germany.
RESULTS: 33 radiological departments and 19 gynecological departments submitted a completed questionnaire. Only 7 departments of radiology reported to have own experience with embolization of uterine leiomyomas, while only 2 departments of gynecology considered embolization as an alternative treatment option in patients with symptomatic leiomyomas. 18/33 radiological departments offer this treatment option but get no patient referrals. Agreement was found concerning the indications for treatment, preclinical evaluation by ultrasound and MRI, preferable location of treatable fibroids, technical approach and pain management.
CONCLUSION: The embolization of uterine leiomyomas in patients with symptomatic myomas is regardless of the well documented high efficacy and low complication rate not yet an established treatment option in Germany. Interventional radiologists and gynecologists have to evaluate the indications for the embolization of uterine leiomyomas together before the procedure is advised to the patient, because it seems mandatory to add this procedure to the standard armamentarium of treatment options in uterine myomas.

Entities:  

Mesh:

Year:  2003        PMID: 14504765     DOI: 10.1007/s00117-003-0937-0

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  23 in total

Review 1.  Pathophysiology of uterine leiomyomas.

Authors:  M Koutsilieris
Journal:  Biochem Cell Biol       Date:  1992-05       Impact factor: 3.626

2.  Arterial embolisation to treat uterine myomata.

Authors:  J H Ravina; D Herbreteau; N Ciraru-Vigneron; J M Bouret; E Houdart; A Aymard; J J Merland
Journal:  Lancet       Date:  1995-09-09       Impact factor: 79.321

3.  Cost analysis of myomectomy, hysterectomy, and uterine artery embolization.

Authors:  Haya Al-Fozan; Joanne Dufort; Marilyn Kaplow; David Valenti; Togas Tulandi
Journal:  Am J Obstet Gynecol       Date:  2002-11       Impact factor: 8.661

4.  Complications after uterine artery embolization for leiomyomas.

Authors:  James B Spies; Amy Spector; Antoinette R Roth; Chandra M Baker; Lauren Mauro; Kerry Murphy-Skrynarz
Journal:  Obstet Gynecol       Date:  2002-11       Impact factor: 7.661

5.  Relative morbidity of abdominal hysterectomy and myomectomy for management of uterine leiomyomas.

Authors:  R E Iverson; D Chelmow; K Strohbehn; L Waldman; E G Evantash
Journal:  Obstet Gynecol       Date:  1996-09       Impact factor: 7.661

6.  Uterine artery embolization for the treatment of uterine leiomyomata midterm results.

Authors:  S C Goodwin; B McLucas; M Lee; G Chen; R Perrella; S Vedantham; S Muir; A Lai; J W Sayre; M DeLeon
Journal:  J Vasc Interv Radiol       Date:  1999-10       Impact factor: 3.464

7.  Morbidity associated with abdominal myomectomy.

Authors:  A I LaMorte; S Lalwani; M P Diamond
Journal:  Obstet Gynecol       Date:  1993-12       Impact factor: 7.661

8.  Danish gynecologists' opinion about hysterectomy on benign indication: results of a survey.

Authors:  Helga Gimbel; Bent Ottesen; Ann Tabor
Journal:  Acta Obstet Gynecol Scand       Date:  2002-12       Impact factor: 3.636

9.  The Ontario Uterine Fibroid Embolization Trial. Part 2. Uterine fibroid reduction and symptom relief after uterine artery embolization for fibroids.

Authors:  Gaylene Pron; John Bennett; Andrew Common; Jane Wall; Murray Asch; Kenneth Sniderman
Journal:  Fertil Steril       Date:  2003-01       Impact factor: 7.329

10.  The Ontario Uterine Fibroid Embolization Trial. Part 1. Baseline patient characteristics, fibroid burden, and impact on life.

Authors:  Gaylene Pron; Marsha Cohen; Jennifer Soucie; Greg Garvin; Leslie Vanderburgh; Stuart Bell
Journal:  Fertil Steril       Date:  2003-01       Impact factor: 7.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.